Company: EHC
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000785161-25-000009
Chunk: 78

Company: Encompass Health Corp
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 78
---
 of substitution and re-substitution, for him in his name, place and stead, in any and all capacities, to sign any and all amendments to this Report and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

Signature Capacity Date /s/  MARK J. TARRPresident and Chief Executive Officer and DirectorFebruary 28, 2025Mark J. Tarr  /s/  DOUGLAS E. COLTHARPExecutive Vice President and Chief Financial OfficerFebruary 28, 2025Douglas E. Coltharp  /s/  ANDREW L. PRICEChief Accounting OfficerFebruary 28, 2025Andrew L. Price  /s/  GREG D. CARMICHAELChairman of the Board of DirectorsFebruary 28, 2025Greg D. Carmichael  /s/  Edward M. CHRISTIE IIIDirectorFebruary 28, 2025Edward M. Christie III/s/  JOAN E. HERMANDirectorFebruary 28, 2025Joan E. Herman  /s/  LESLYE G. KATZDirectorFebruary 28, 2025Leslye G. Katz  /s/  PATRICIA A. MARYLANDDirectorFebruary 28, 2025Patricia A. Maryland  /s/  KEVIN J. O’CONNORDirectorFebruary 28, 2025Kevin J. O’Connor  /s/  CHRISTOPHER R. REIDYDirectorFebruary 28, 2025Christopher R. Reidy/s/  NANCY M. SCHLICHTINGDirectorFebruary 28, 2025Nancy M. Schlichting  /s/  TERRANCE WILLIAMSD